RGS2 and prostate adenocarcinoma: Recent studies in different cell systems showed that RGS2 attenuates G protein signaling in chemo-resistant non-small cell lung cancer cell lines (80), but promotes AKT phosphorylation in human prostate adenocarcinoma cell line LNCaP cells (52).